Email Us
Prostate Cancer (PCA) Is A Difficult Disease To Understand

Prostate Cancer (PCA) Is A Difficult Disease To Understand

Table of Content [Hide]

    Prostate cancer (PCa) is a difficult disease to understand. The tumor's genetic diversity increases as mutations accumulate, resulting in distinct subclones. Non-genetic intra-tumoral heterogeneity, the cellular differentiation state, and the interaction between subclonal evolution and transcriptional heterogeneity are poorly understood. The authors performed single-cell RNA sequencing on 14 untreated PCa patients in this study. They developed a comprehensive cell atlas of PCa patients and mapped developmental states onto tumor subclonal evolution. They found distinct subclones in PCa patients and then divide tumor cells into four transcriptional subtypes: EMT-like (subtype 0), luminal A-like (subtype 1), luminal B/C-like (subtype 2), and basal-like (subtype 3). These subtypes are organized hierarchically into stem cell-like and differentiated states. Surprisingly, multiple subclones within a single primary tumor have distinct preferential subtype combinations. 

    Furthermore, subclones exhibit varying levels of communication with other cell types within the tumor ecosystem, which may modulate the distinct transcriptional subtypes of the subclones. Notably, they discovered that tumor cell transcriptional heterogeneity and cellular ecosystem diversity correlate with features of a poor prognosis by integrating TCGA data. Their research examines subclonal and transcriptional heterogeneity and its implications for patient prognosis.




    Related CapitalBiotech Products

    CapitalBiotech News & Blog

    • What is a Microfluidic Chip?September 27, 20221. Basic definition of microfluidic chipMicrofluidic chip, also known as Lab-on-chip, is a science and technology characterized by the manipulation of fluids in the micron-scale space.At present, the ...view
    • Exploring the Benefits of Genome Sequencing ServicesJune 26, 2023Genome sequencing services have revolutionized the field of genetics and healthcare by providing valuable insights into our genetic makeup. With advancements in technology, it is now possible to decod...view
    • Why Choose Microarrays over Other Technologies?November 10, 2023Microarrays are becoming an increasingly popular choice for biologists and researchers worldwide. With the help of advanced technology, these arrays provide a cost-effective and efficient way to analy...view
    • Technical Principles and Functions of Gene SequencingDecember 1, 2022Gene sequencing is a new type of genetic testing technology, which can analyze and determine the full sequence of genes from blood or saliva, predict the possibility of suffering from various diseases...view
    • CapitalBiotech: Advancing Breast Cancer Research with Microarray ScannersFebruary 7, 2024Introduction to CapitalBiotech and BRCA Gene ResearchCapitalBiotech, a global leader in biotechnology, is making significant strides in breast cancer research with its advanced microarray scanners. These inst...view
    • Diagnostic Methods for Brain CancerApril 4, 2023Brain cancer is a very difficult-to-treat neurological disease, also known as a brain tumor. Many patients ask the question, can brain cancer be cured? The earlier brain cancer is treated, the better....view
    Products
    86-10-69002900
    Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing